Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov;78(16):1751-1755.
doi: 10.1007/s40265-018-0997-0.

Pyrotinib: First Global Approval

Hannah A Blair  1
Affiliations
Review

Pyrotinib: First Global Approval

Hannah A Blair. Drugs. 2018 Nov.

Abstract

Pyrotinib is an irreversible dual pan-ErbB receptor tyrosine kinase inhibitor developed for the treatment of HER2-positive advanced solid tumours. Based on positive results in a phase II trial, the drug recently received conditional approval in China for use in combination with capecitabine for the treatment of HER2-positive, advanced or metastatic breast cancer in patients previously treated with anthracycline or taxane chemotherapy. This article summarizes the milestones in the development of pyrotinib leading to this first global approval for the treatment of HER2-positive advanced breast cancer.

PubMed Disclaimer

References

    1. Cancer Treat Rev. 2018 Jun;67:10-20 - PubMed
    1. J Clin Oncol. 2017 Sep 20;35(27):3105-3112 - PubMed
    1. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Oct 15;1033-1034:117-127 - PubMed
    1. Eur J Pharm Sci. 2017 Dec 15;110:51-61 - PubMed
    1. Breast. 2018 Jun;39:80-88 - PubMed

MeSH terms

LinkOut - more resources